The Bank of New York Mellon
BNY
$143.30
+0.85%
Bank of New York Mellon (BNY) is the world's largest global custody bank, providing securities servicing, custody, fund administration, clearing, collateral management, and investment management to institutions, corporations, and individual investors across 35 countries and more than 100 markets, with roughly $59.3 trillion in assets under custody and administration and about $2.2 trillion in assets under management. Its competitive identity rests on an oligopolistic, fee-based infrastructure franchise — BNY, State Street, and JPMorgan dominate custody — where scale, regulatory capital strength, and deep client entrenchment create high switching costs and recurring revenue that is largely insulated from credit cycles. The current investor narrative centers on operating leverage and margin expansion: pre-tax margin has climbed steadily from roughly 14.7% in Q4 2024 to 22.2% in Q2 2026, driven by expense discipline, a favorable rate environment boosting net interest revenue, and rising asset values that lift fee revenue on AUC/A. Debate now hinges on whether this margin trajectory is durable as rates eventually ease, and on the stock's extraordinary re-rating — shares have more than doubled over the past year as the market has rewarded the franchise's earnings inflection and capital return.…
BNY
The Bank of New York Mellon
$143.30
Related headlines
BNY 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on The Bank of New York Mellon's 12-month outlook, with a consensus price target around $163.53 and implied upside of +14.1% versus the current price.
Average Target
$163.53
0 analysts
Implied Upside
+14.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$135 - $182
Analyst target range
Coverage is robust, with 15 analysts and a consensus recommendation of "buy" (mean rating 2.12 on a scale where lower is more bullish). The average target price of $163.53 implies roughly 14.1% upside from the current $143.30, and the consensus leans clearly bullish — the institutional ratings log shows a wall of Buy/Overweight ratings from Truist, JPMorgan, Argus, BofA, and Barclays, balanced against Neutral/Equal Weight/Sector Perform stances from Citigroup, Wells Fargo, RBC, and Evercore ISI. Notably, the ratings are almost entirely reiterations rather than upgrades or downgrades, suggesting analysts are holding conviction through the recent pullback rather than chasing the stock.
The target range of $135.00 to $182.00 is wide — a 35% spread from low to high — signaling meaningful disagreement about the margin story. The $182 high target implies roughly 27% upside and would require the market to embrace multiple expansion toward 18–19x forward earnings on sustained 20%+ operating margins and continued capital return; the $135 low target sits just below the current price and effectively prices in margin compression or a rate-driven NIR headwind, essentially a "no upside" scenario. The fact that the low target is only ~6% below the current price while the high is 27% above skews the risk/reward favorably, and the consensus revenue estimate of $25.67 billion (range $25.11–$26.12 billion) implies modest top-line stability rather than growth — reinforcing that this is a margin-and-capital-return story, with the tight revenue range but wide price-target range highlighting that the debate is entirely about profitability durability rather than demand.
Bulls vs Bears: BNY Investment Factors
The bull case rests on a genuine, multi-quarter operating leverage story: EPS up 26% on flat revenue, pre-tax margin up from 14.7% to 22.2%, and a still-modest 13.78x forward PE with a 0.56 PEG and 14.1% analyst target upside. The bear case is that this margin expansion is partly rate-dependent, revenue is actually shrinking 1.66% year-over-year, and the stock has already re-rated from ~9x to 15.6x trailing earnings — near the top of its historical band — while momentum has turned negative with a 6.63% one-month decline. On balance, the bull evidence is currently stronger: the margin improvement is consistent across four consecutive quarters, the balance sheet is solid, and the valuation is not stretched relative to growth. The single most important tension is margin durability as rates eventually ease — if the 22% operating margin holds through a rate-cutting cycle, the current multiple is cheap; if it reverts toward 15–18%, the re-rating is undeserved and the stock has limited support.
Bullish
- Operating leverage driving EPS surge: Diluted EPS rose 26% year-over-year to $2.43 in Q2 2026 from $1.93, achieved on essentially flat revenue ($10.192B vs $10.364B). Cost and expenses fell to $7.924B from $8.525B, showing expense discipline converting directly into earnings growth.
- Margin expansion is multi-quarter and consistent: Pre-tax margin climbed from 14.7% in Q4 2024 to 22.2% in Q2 2026, with net margin rising sequentially from 12.6% (Q1 2025) to 14.5% (Q4 2025) to 16.5% (Q1 2026) to 17.3% (Q2 2026). Gross margin expanded from 48.1% to 56.0% year-over-year, a structural rather than one-off improvement.
- Valuation still screens cheap on growth: At 15.56x trailing and 13.78x forward earnings, BNY trades at roughly a 11% discount to its own forward multiple, and the 0.56 PEG ratio implies the market pays well under one times growth despite 26% EPS growth. P/B of 1.85x and P/S of 2.02x remain modest for a 12.5% ROE franchise.
- Analyst consensus bullish with favorable skew: 15 analysts carry a 'buy' consensus (mean 2.12) with an average target of $163.53, implying 14.1% upside from $143.30. The low target of $135 sits only ~6% below the current price while the high of $182 implies 27% upside, skewing risk/reward favorably.
Bearish
- Revenue is flat to slightly declining: Q2 2026 revenue of $10.192B fell 1.66% year-over-year, and the top line has oscillated in a $9.65–$10.36B band for multiple quarters. With consensus revenue of $25.67B implying stability rather than growth, the entire thesis rests on margin expansion that has no revenue tailwind.
- Margin durability hinges on rate environment: The margin expansion was partly driven by a favorable rate environment boosting net interest revenue; interest income of $5.94B in Q2 2026 versus interest expense of $4.494B is a key profit lever. If rates ease, NIR compresses and margins could revert toward the 15–18% range seen in 2024–2025, undermining the re-rating.
- Valuation re-rated to top of historical band: BNY's PE ranged roughly 8.5x–11.7x from mid-2023 through mid-2025; the current 15.6x sits near the top of that band, and P/B of 1.85x compares with 1.26x–1.48x as recently as Q3 2025–Q2 2025. The stock has already been paid for the earnings inflection, leaving less room for disappointment.
- Momentum has decisively deteriorated: Despite a 1,284.5% one-year gain, the stock is down 6.63% over one month and 8.80% over three months, underperforming SPY by 7.85 and 11.49 percentage points respectively. The sequence of lower highs from $164.84 to $137.64 signals distribution rather than accumulation.
BNY Technical Analysis
BNY is in a powerful, sustained uptrend that has carried shares from a 52-week low of $103.11 to a high of $165.84, a range of roughly 61%. At the current price of $143.30, the stock sits at approximately 64% of its 52-week range — well off the highs but far above the lows — and the reported 1-year change of 1,284.5% (versus SPY's 15.53%) reflects a massive re-rating that has left the stock consolidating its gains rather than pressing to new highs. This positioning suggests a stock digesting a parabolic advance rather than one breaking down, but the distance from the high implies momentum has clearly cooled.
Short-term momentum is decisively negative and diverging from the longer-term trend: the stock is down 6.63% over the past month and 8.80% over three months, against a 1-year gain of 1,284.5%. Relative strength confirms the deceleration — BNY has underperformed SPY by 7.85 percentage points over one month and 11.49 points over three months, even as its 1-year relative strength remains a staggering +1,269 points. This divergence between a still-dominant long-term trend and a deteriorating intermediate trend is classic mean-reversion behavior after a vertical move, and the recent sequence of lower highs — from $164.84 in early September to $137.64 on October 14 before a bounce to $143.30 — signals distribution rather than accumulation.
Key technical levels are well defined: support sits at the $137–$138 area (the October 14 low of $137.64) with the 52-week low of $103.11 as the ultimate floor, while resistance is the 52-week high of $165.84, with intermediate supply near $160–$164 where the stock repeatedly stalled in August and September. A breakout above $165.84 would confirm resumption of the primary uptrend and likely trigger momentum buying, whereas a breakdown below $137.64 would validate the lower-highs pattern and open a test of the $130s. With a beta of 1.051, BNY's volatility is roughly in line with the market — only about 5% more volatile than SPY — though the 16.5% max drawdown and 6.08 million average volume indicate meaningful two-way risk for position sizing.
Beta
1.05
1.05x market volatility
Max Drawdown
-16.5%
Largest decline past year
52-Week Range
$105-$166
Price range past year
Annual Return
+1284.5%
Cumulative gain past year
| Period | BNY Return | S&P 500 |
|---|---|---|
| 1m | -6.6% | +0.2% |
| 3m | -8.8% | +2.9% |
| 6m | +1304.9% | +8.4% |
| 1y | +1284.5% | +14.9% |
| ytd | +1313.2% | +11.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BNY Fundamental Analysis
Revenue is essentially flat but stabilizing at a high level: Q2 2026 revenue of $10.192 billion was down 1.66% year-over-year versus $10.364 billion in Q2 2025, following $9.863 billion in Q1 2026 and $10.067 billion in Q4 2025. The multi-quarter trend shows revenue oscillating in a $9.65–$10.36 billion band — Q1 2025's $9.651 billion was the trough, and the last four quarters have clustered near $10 billion — indicating a mature, fee-driven franchise where growth comes from asset values and mix rather than volume. Within the segment data, Financial Service at $2.864 billion and Investment Advisory/Management/Administrative at $796 million dominate the disclosed mix, with Distribution and Shareholder Services a negligible $38 million; the flat top line means the investment case rests on margin and capital return rather than revenue acceleration.
Profitability is the standout story. Q2 2026 net income of $1.761 billion on $10.192 billion of revenue produced a 17.3% net margin and 22.2% operating margin, up sharply from 13.7% net margin and 17.7% operating margin in Q2 2025, while gross margin expanded from 48.1% to 56.0% over the same period. The trajectory is consistent across quarters — net margin rose from 12.6% (Q1 2025) to 14.5% (Q4 2025) to 16.5% (Q1 2026) to 17.3% (Q2 2026) — and diluted EPS climbed from $1.93 to $2.43 year-over-year, a 26% increase on flat revenue. This is textbook operating leverage: expenses are being held down (cost and expenses fell to $7.924 billion from $8.525 billion) while revenue holds, and the 48.9% gross margin and 17.5% operating margin reported in the valuation data are consistent with a high-quality fee franchise.
Balance sheet and cash flow are solid but require nuance. Debt-to-equity is a modest 0.764, ROE is 12.5%, and ROA is 1.26% — typical, healthy levels for a custody bank with a 10–12x equity multiplier. Free cash flow is lumpy due to securities portfolio churn: TTM FCF is $1.592 billion, but quarterly FCF swung from -$3.63 billion in Q1 2026 to +$1.975 billion in Q2 2026, reflecting working-capital and investment-portfolio flows rather than operating stress, while Q2 operating cash flow was a healthy $2.462 billion. The company returned capital aggressively — $1.103 billion of buybacks and $453 million of dividends in Q2 alone — and the 2.06% dividend yield with a 30.4% payout ratio leaves ample room for continued repurchases; the low current ratio of 0.704 is normal for a bank and not a liquidity concern.
Quarterly Revenue
$10.2B
2026-06
Revenue YoY Growth
-1.7%
YoY Comparison
Gross Margin
56.0%
Latest Quarter
Free Cash Flow
$1.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BNY Overvalued?
Because BNY is solidly profitable (Q2 2026 net income of $1.761 billion), the PE ratio is the appropriate primary metric. The stock trades at 15.56x trailing earnings and 13.78x forward earnings — a roughly 11% discount from trailing to forward, implying the market expects EPS growth of about 13% over the next twelve months, consistent with the margin-expansion trajectory. The PEG ratio of 0.561 is strikingly low, suggesting the market is paying well under one times growth, and the 2.02x price-to-sales and 1.85x price-to-book are modest for a franchise with 12.5% ROE.
Against the broader financial services sector, BNY screens as a value proposition: a 15.6x trailing PE and 1.85x P/B are below the multiples typically commanded by large-cap financial infrastructure names, and the 13.8x forward PE is a clear discount to the market's ~20x-plus average. The 0.56 PEG ratio quantifies the gap — the stock is priced as if growth will stall, despite EPS rising 26% year-over-year in Q2 2026. The premium/discount debate is really about durability: if the 22% operating margin holds, the current multiple is cheap; if rate cuts compress net interest revenue and margins revert toward the 15–18% range of 2024–2025, the discount is deserved.
Historical context is important and cuts both ways. BNY's PE ratio has ranged from roughly 8.5x–11.7x in mid-2023 through mid-2025, and the current 15.6x trailing PE sits near the top of that multi-year band — the stock has re-rated from a ~1.1x P/B, ~9x PE value name into a mid-teens multiple. The P/B of 1.85x compares with 1.26x–1.48x as recently as Q3 2025–Q2 2025, confirming the market now prices in optimistic, durable margin expansion. That leaves less room for disappointment: the valuation is no longer deep value, but the 13.8x forward PE and 0.56 PEG suggest the re-rating has not yet reached stretched territory if earnings delivery continues.
PE
15.6x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 9x~18x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-1.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the fragility of the margin story. Revenue actually declined 1.66% year-over-year in Q2 2026 to $10.192B, meaning all earnings growth came from cost reduction — cost and expenses fell to $7.924B from $8.525B — and expense discipline has finite runway before it impairs the franchise. Net interest revenue is a material profit lever (interest income of $5.94B against $4.494B of interest expense in Q2 2026), so a rate-cutting cycle directly compresses the largest driver of recent margin gains. Free cash flow is lumpy and unreliable as a valuation anchor, swinging from -$3.63B in Q1 2026 to +$1.975B in Q2 2026, and the 0.704 current ratio, while normal for a bank, offers little buffer if securities-portfolio churn accelerates.
Market and competitive risks are dominated by valuation compression. The stock has re-rated from roughly 8.5x–11.7x PE in mid-2023 through mid-2025 to 15.6x trailing today, with P/B at 1.85x versus 1.26x–1.48x as recently as Q3 2025–Q2 2025 — the market now prices in durable margin expansion, so any disappointment could trigger multiple contraction on top of earnings revision. The custody oligopoly (BNY, State Street, JPMorgan) is stable but not immune to fee compression and passive-mix shifts that pressure servicing revenue. With a beta of 1.051, BNY is only about 5% more volatile than the market, but its 1,284.5% one-year gain versus SPY's 15.53% means sector rotation out of financial infrastructure winners would hit disproportionately; the 7.85-point one-month and 11.49-point three-month relative underperformance versus SPY already shows this rotation beginning.
In a worst-case scenario, rate cuts compress net interest revenue, margins revert toward the 15–18% range of 2024–2025, and the market re-rates the stock back toward its historical 10–12x PE band. From the current $143.30, a retest of the 52-week low of $103.11 would represent a loss of roughly 28%, and the analyst low target of $135 implies about 6% downside as a nearer-term floor. The 16.5% max drawdown already recorded shows the stock can move violently, and a breakdown below the October 14 low of $137.64 would validate the lower-highs pattern and open a test of the $130s. A realistic adverse outcome is a 15–28% decline, with the low end requiring both margin compression and multiple contraction simultaneously.